Application

G

SmithKline Beecham Limited

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97446036
Filing Date: 06/07/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97446036
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\974\460\97446036\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT G
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) orange is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of stylized letter "G" appearing in orange.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 376 x 378
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK SmithKline Beecham Limited
*MAILING ADDRESS 980 Great West Road
*CITY Brentford, Middlesex
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY England
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
TW89GS
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE private company limited by shares (prc)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED United Kingdom
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; chemical, biochemical and biological preparations and agents for medical purposes; vaccines; adjuvants for medical purposes; diagnostic preparations; medicated and sanitizing soaps and detergents; drug delivery agents that facilitate the delivery of pharmaceutical preparations
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 010 
*IDENTIFICATION Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; bioelectronic treatment devices for medical purposes; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices for the deferred, controlled or immediate release of pharmaceutical preparations into the human body; surgical implants comprising artificial material
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting clinical trials; genetic testing and genetic fingerprinting for research purposes; scientific consulting; medical laboratory services; Providing medical and scientific research information; design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing and genetic fingerprinting for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Christopher M. Hanes
ATTORNEY DOCKET NUMBER 84181494
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME GSK
INTERNAL ADDRESS 5.5A, LBP
STREET 5 Moore Drive
CITY Research Triangle Park
STATE North Carolina
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 27709
PHONE 919-450-7041
FAX 919-315-3023
EMAIL ADDRESS trademarks@gsk.com
OTHER APPOINTED ATTORNEY Elizabeth K. Rucki
CORRESPONDENCE INFORMATION
NAME Christopher M. Hanes
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@gsk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 4
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1400
*TOTAL FEES PAID 1400
SIGNATURE INFORMATION
SIGNATURE /Christopher M. Hanes/
SIGNATORY'S NAME Christopher M. Hanes
SIGNATORY'S POSITION Attorney of record, NC Bar member
SIGNATORY'S PHONE NUMBER 919-450-7041
DATE SIGNED 06/07/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97446036
Filing Date: 06/07/2022

To the Commissioner for Trademarks:

MARK: G (stylized and/or with design, see mark)
The literal element of the mark consists of G. The color(s) orange is/are claimed as a feature of the mark. The mark consists of stylized letter "G" appearing in orange.
The applicant, SmithKline Beecham Limited, a private company limited by shares (prc) legally organized under the laws of United Kingdom, having an address of
      980 Great West Road
      Brentford, Middlesex TW89GS
      England
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; chemical, biochemical and biological preparations and agents for medical purposes; vaccines; adjuvants for medical purposes; diagnostic preparations; medicated and sanitizing soaps and detergents; drug delivery agents that facilitate the delivery of pharmaceutical preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 010:  Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; bioelectronic treatment devices for medical purposes; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices for the deferred, controlled or immediate release of pharmaceutical preparations into the human body; surgical implants comprising artificial material
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting clinical trials; genetic testing and genetic fingerprinting for research purposes; scientific consulting; medical laboratory services; Providing medical and scientific research information; design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing and genetic fingerprinting for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Christopher M. Hanes. Other appointed attorneys are Elizabeth K. Rucki. Christopher M. Hanes of GSK, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      5.5A, LBP
      5 Moore Drive
      Research Triangle Park, North Carolina 27709
      United States
      919-450-7041(phone)
      919-315-3023(fax)
      trademarks@gsk.com
The docket/reference number is 84181494.
Christopher M. Hanes submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Christopher M. Hanes
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gsk.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).

Declaration

Declaration Signature

Signature: /Christopher M. Hanes/   Date: 06/07/2022
Signatory's Name: Christopher M. Hanes
Signatory's Position: Attorney of record, NC Bar member
Signatory's Phone Number: 919-450-7041
Signature method: Sent to third party for signature
Payment Sale Number: 97446036
Payment Accounting Date: 06/07/2022

Serial Number: 97446036
Internet Transmission Date: Tue Jun 07 11:09:38 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-202206071109382775
40-97446036-820c4c5d26b649572177ea47e607
a3133f28773460b097e0bdf5fb2f941c125-DA-0
9370546-20220607101858832039

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed